The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1219
ISSUE1219
October 10, 2005
Second-Generation Antipsychotics - Aripiprazole Revisited
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Second-Generation Antipsychotics - Aripiprazole Revisited
October 10, 2005 (Issue: 1219)
Aripiprazole (Abilify - Bristol-Myers Squibb/Otsuka), a second-generation (atypical) antipsychotic drug, was approved by the FDA in 2002 for treatment of schizophrenia and more recently for bipolar disorder as well. It has been promoted as causing...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.